Ratish Nair, CEO, Sanrad Medical Systems
The refurbished equipment market operates similar to other new equipment business, Â except for the fact that the business is concentrated more in the tier II-III cities. Presently, the refurbished market is approximately 20 percent of the overall equipment sold and almost 30 percent of the sales in the private sector.
Maninder Singh Grewal, Chairman and MD, HealthFore Technologies Limited
The demand for high quality and specialty healthcare services in Tier 2 and Tier 3 cities will play tremendous role in furthering mHealth and Telemedicine services. As I mentioned, we see India as a huge potential in the coming years.
Dr Tapan Ghose, Director and HOD Cardiology, Paras Hospital
Next 10 years for interventional cardiology, we will see tremendous amount of growth in terms of usage of new technology, growing numbers in terms of interventions, growth of more cath labs in the state and district head quarters. This is going to give our population more access to tertiary care facilities at doorstep.
Dr Arun Raizada, Senior Consultant and Head Biochemistry, Department of Laboratory Science, Medanta â€“ The Medicity
With the number of testing parameters increasing day by day and with the rising demand from the customers, we need to go in for more automation. Total laboratory automation will be the only solution, because this not only improves turnaround time, but also the quality of results and less dependency on manpower.
Dr Neeraj Mehta, Regional Head, International Oncology Cancer Centre, Dr L H Hiranandani Hospital
International Oncology Services has taken many initiatives and the aim is to widen the spread of cancer care across tier II cities. This has been embedded in our plans to ensure that not only is the infrastructure improved across all parts of the country but also to pick up cases early and treat them so as to reduce morbidity and mortality.
Pradeep K Jaisingh, MD and CEO, International Oncology Centre
Cancer is a disease, which needs a much better allocation of funds and attention from the government as it contributes double the death rate than malaria, HIV and tuberculosis put together.
Kiran Mazumdar Shaw, Chairman & Managing Director, Biocon Limited
If young doctors do not wish to go to rural India then one have to use technology to link rural India to advance centres. We must use technology to bridge this gap and that technology is eHealth. eHealth is about diagnosis, which is very important, as only through proper diagnosis one can deliver cost effective treatment.
Dr K K Kalra, CEO, NABH
As of today, there are just 200 NABH accredited hospitals. It requires a lot of commitment and continuous improvement. Just getting an accreditation is not enough. Sustaining it is very difficult as the board keeps a serious surveillance on those accredited for renewal. In the first go, accreditation is given for just three years.
Dr Narender Saini, General Secretary of Indian Medical Association
We are more of paper tiger, make policies, speak beautifully on those policies but when we make execution I donâ€™t know where our vision goes.
Dr Girdhar J Gyani, Director General, Association of Healthcare Providers (India)
Advocacy is the major issue. To ensure that we are allowed to function to deliver universal health coverage, regulations should be objective, taxation should be reasonable and other conditions like lands, should be in such a way that they are able to meet objective of both our and government.
Dr Sameer Ahmed Khan, CEO, Rockland Hospitals GroupÂ
The rise of multispecialty hospitals is a more in the right direction for the wealth in the country. The patient gets everything under the same roof which is helpful in treating all the co-morbid conditions as well. Even the treating doctors get the right support for them colleagues in other specialties.
Aman Gupta, Health Policy Analyst
It is high time that we all realize that â€˜Access to Healthcareâ€™ is not just a function of the health ministry. Whatâ€™s required today is a futuristic yet realistic blueprint that is able to transform this into reality. As for the Indian pharmaceutical industry, the players need to evolve from just being a manufacturer of generics drugs to a contributor towards ensuring global health.
Dr Naresh Trehan, Chairman and Managing Director, Medanta â€“ The Medicity
Telemedicine has very huge potential but as of now it seems to be in a nascent stage. No less than 90 per cent of the diseases can actually be treated or diagnosed with the help of telemedicine or video conferencing. Now things are taking shape. With ever evolving technology, it would be easy now to connect and incorporate telemedicine over Skype or with advanced webcams. This will immensely help in connecting with the rural areas.
Prof Anupam Sibal, Group Medical Director, Apollo Hospitals Group, New Delhi
We strongly believe that India will find its rightful place as the Global Healthcare Destination. We have developed international delivery capabilities and demonstrated our global excellence in almost all specialities.
Dr A K Mahapatra, Director, AIIMS, Bhubaneswar
There is hug shortage of doctors and whatever we have they are not very inclined to serve in rural areas. In such a scenario, arenâ€™t the programmes such as National Rural Health Mission (NRHM) too ambitious when it says there will be six doctors in every Community Healthcare Centre while there are no MBBS doctors even at some places in Primary Healthcare Centres.
Dr Ramakanta Panda, VC & MD, Asian Heart Institute, Mumbai
In India, the healthcare industry is at par with international counterparts. While the only point is that there is lack of trained people. There is huge gap in terms of the percentage at which the healthcare industry and the trained population is growing. Also, to make healthcare an investment friendly industry, I recommend the Government to announce attractive tax benefits or incentives similar to hospitality and IT sector.